The European Medicines Agency yesterday said it's launching an infringement procedure against...

|By:, SA News Editor

The European Medicines Agency yesterday said it's launching an infringement procedure against Roche (RHHBY.OB) for not properly looking into 80,000 reports of issues received from U.S. patients and doctors relating to 19 of the company's drugs, including best-sellers Herceptin and Avastin. If found guilty of wrongdoing, Roche could face a fine of up to 5% of its annual revenues.